Supporting information for Hanway et al. (2002) Proc. Natl. Acad. Sci. USA, 10.1073/pnas.152264899

 

Table 6. Growth response of MMS-treated strains as determined by competition assays

ORF

RF 0.001%4pts

RF 0.01%4pts

High sensitivity

COQ4*

0.72

0.70

COX7

0.82

0.78

COX18

0.87

0.85

ESC4*†‡

0.69

0.64

HAP2

0.85

0.85

HOM3*

0.64

0.63

IKI3

0.88

0.73

IRA2*

0.83

0.79

ISA1

0.83

0.88

ISM1

0.85

0.84

MMS2§

0.85

0.70

MRPL7

0.78

.087

MUS81§

0.85

0.79

PET309

0.84

0.79

RAD5§

0.68

0.66

RSM22

0.66

0.63

TIM13*†‡

0.85

0.76

YCL061C*

0.72

0.69

YER049W*

0.71

0.68

YER084W

0.85

0.86

YER097W

0.85

0.85

YGR228W

0.88

0.81

YHR207C

0.88

0.84

YLR368C

0.88

0.87

YLR376C*†‡

0.82

0.59

YOR006C

0.83

0.87

YOR338W

0.88

0.84

YPL098C

0.74

0.74

Moderate sensitivity

CKB2

1.00

0.79

CEM1

0.87

1.01

CTR1

1.02

0.64

DOA1

0.98

0.69

DRS2

1.00

0.84

ELA1

0.81

0.95

GBP2

0.84

0.96

HOS2

0.88

0.93

ILV1

0.99

0.83

ISC1

0.89

0.86

KRE11

0.86

1.00

LST4

0.98

0.74

MAC1*

0.94

0.73

MEC3§

0.95

0.83

MRPL33

0.80

0.90

MSS1

0.79

0.91

MSY1

0.88

1.05

PDB1

0.80

0.91

PHB1

0.89

0.88

POS5

0.92

0.88

PPH3*

0.99

0.67

RAD14§

0.89

0.73

RAD17§

1.02

0.88

REV1§

1.06

0.84

RPL34A

0.86

0.98

SAP155

0.76

1.03

SBA1

0.87

0.94

SHU1

0.97

0.69

SLT2

0.92

0.87

TOF1

0.97

0.81

TOS10

0.97

0.87

TRP3

0.98

0.73

VPS29

0.66

1.06

YAL011W

0.99

0.84

YBR223C*

0.89

0.70

YDR078C

0.93

0.69

YDR338C

0.84

0.97

YER028C

0.86

0.89

YER050C

0.85

1.04

YER093C-A

0.94

0.88

YER083C

0.98

0.76

YGR136W*

0.89

0.67

YGR138C

0.87

0.90

YGR182C

0.96

0.82

YHR045W

0.97

0.63

YKL098W*

0.98

0.62

YKR021W

0.80

0.89

YKR033C

075

0.93

YLR135W

1.04

0.65

YLR374C

0.80

1.06

YMR030W

0.84

0.94

YNL201C

1.00

0.60

YOR284W

0.91

0.84

YPL170W

1.05

0.78

YPR123C

1.04

0.66

YPR153W

1.03

0.76

Low sensitivity

ADE6

0.89

1.06

APA1

0.92

0.95

AXL1

0.89

0.90

BNI4

0.89

0.94

BUD9

0.92

0.95

CDC50§

0.96

0.91

CLU1

0.90

0.99

DIT2

0.91

0.99

EGD2

0.90

0.97

FMS1

0.92

1.01

FPS1

0.91

0.89

FTH1

0.90

0.97

GLN3

0.92

1.04

HVG1

0.91

0.96

HXT2

0.90

0.99

MDJ2

0.89

1.00

PCD1

0.97

0.91

PET111

0.99

0.89

PHR1§

0.89

0.91

PPT1

0.90

0.98

QRI8

0.89

1.00

RAD9§

0.99

0.90

REV3§

1.07

0.89

RIM101

0.97

0.92

RTG2

0.95

0.91

SCS7

0.95

0.89

SLG1

0.90

0.95

SNF7

0.94

0.92

SPO7

0.97

0.91

STB4

0.91

1.00

STF1

0.90

0.93

STP22

0.94

0.89

SYF2

0.89

0.97

TOM6

0.93

0.90

UBI4

1.02

0.91

URE2

0.89

1.01

VPS36

0.92

0.90

YBL065W

0.91

0.91

YCR007C

0.91

0.94

YDR132C

0.90

0.93

YDR540C

0.97

0.92

YEL064C

0.90

0.97

YER041W

0.88

0.94

YFR056C

0.90

0.98

YGR066W

0.89

0.90

YGR122W

0.95

0.92

YGR206W

0.89

0.89

YHL005C

0.98

0.92

YHR189W

0.99

0.92

YLL029W

0.89

0.91

YLR239C

0.92

0.89

YLR401C

0.90

0.98

YLR412W

0.99

0.91

YLR415C

0.92

0.96

YMR007W

0.92

0.99

YMR018W

0.92

1.01

YMR034C

0.92

0.99

YMR163C

0.89

0.97

YMR251W

0.91

0.98

YOR192C

0.93

0.92

YPL047W

1.00

0.90

YPL184C

0.95

0.89

YPR126C

0.89

0.91

Relative fitness ratios (RF) from samples treated with 0.001% or 0.01% methyl methanesulfonate (MMS). RF4pts values are determined by calculating the growth rate of the strains using samples taken after 7, 13, and 20 generations of growth and computing the ratio of the growth rates in treated versus untreated samples. High sensitivity, both relative fitness ratios below 0.88; moderate sensitivity, one ratio below 0.88; low sensitivity, one ratio below 0.92.

*Strains chosen for individual analysis.

Strains displaying increased sensitivity during individual treatment.

Successfully complemented strains.

Previously implicated in DNA damage repair, or known to be MMS sensitive.